Kubica, Krzysztof, and Aleksander Mazurek. “VEMURAFENIB AS A SELECTIVE INHIBITOR OF THE SERINE THREONINE-PROTEIN KINASE B-RAF, USED IN THE TREATMENT OF MELANOMA”. Prospects in Pharmaceutical Sciences 14, no. 8 (December 2, 2016): 52–56. Accessed November 23, 2024. https://prospects.wum.edu.pl/index.php/pps/article/view/117.